Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals Selects Linical to Advance FDA-Cleared Phase 1/2 Clinical Trial of Telomir-Zn in Triple-Negative Breast Cancer
Global CRO Brings Extensive Oncology Experience, Including Breast Cancer and Early-Phase Clinical Development